Alex M. DePaoli

Corporate Officer/Principal bei Sansum Diabetes Research Institute

Health Technology

Commercial Services

Profil

Alex M.
DePaoli is currently a Senior Endocrinologist at Sansum Diabetes Research Institute.
Previously, he held positions as Director-Global Development at Amgen, Inc., Chief Medical Officer at InteKrin Therapeutics, Inc., and Chief Medical Officer & Senior Vice President at NGM Biopharmaceuticals, Inc. (2010-2019).

Aktive Positionen von Alex M. DePaoli

Unternehmen	Position	Beginn
Sansum Diabetes Research Institute Sansum Diabetes Research Institute Miscellaneous Commercial ServicesCommercial Services Sansum Diabetes Research Institute is an American company that is dedicated to improving the lives of people affected by diabetes through research, education, and care.	Corporate Officer/Principal	-

Alle aktiven Positionen von Alex M. DePaoli

Ehemalige bekannte Positionen von Alex M. DePaoli

Unternehmen	Position	Ende
AMGEN INC.	Corporate Officer/Principal	-
NGM BIOPHARMACEUTICALS, INC.	Technik-/Wissenschafts-/F&E-Leiter	20.03.2019
InteKrin Therapeutics, Inc. InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA.	Technik-/Wissenschafts-/F&E-Leiter	-

Sehen Sie sich die Erfahrung von Alex M. DePaoli im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen